• Adherence to Wegovy far outpaces older weight loss drugs: Cleveland Clinic study

    Patients taking Novo Nordisk's weight loss drug Wegovy in 2021 and 2022 were three times more likely to continue taking the medication a year later compared to older weight loss therapies, according to a study published Dec. 6 in Obesity. 
  • Transform Your Hospital Operations: A Virtual Summit

    Sponsored
    Nearly 190 health systems are reimagining hospital operations with AI. Learn how, here.
  • How 2 pharmacy leaders became hospital CEOs

    As more systems create a C-suite role for pharmacy leaders, health systems and hospitals are increasingly promoting these executives to non-pharmacy roles, such as CEO.
  • Eli Lilly obesity drug hits pharmacy shelves

    Zepbound, a newly approved obesity drug from Eli Lilly, hit the market Dec. 5. 
  • The Mark Cuban effect on drug pricing

    In January 2022, entrepreneur and "Shark Tank" star Mark Cuban launched an online pharmacy that priced 100 medications by their manufacturing fee, a 15% markup, and a shipping and handling fee. Less than two years later, Express Scripts and CVS are following suit. 
  • Most of ChatGPT's answers to drug questions are wrong: Study

    Nearly 75% of ChatGPT's answers to drug-related questions are incomplete or wrong, according to a study conducted at Brookville, N.Y.-based Long Island University.
  • 3 patients die in cancer drug trial

    Three patients reportedly died in a Merus clinical trial of a new lung cancer treatment.
  • Elevance to launch digital pharmacy under Carelon

    Elevance Health is launching CarelonRx Pharmacy, a digital and home delivery pharmacy subsidiary, in 2024.
  • Cancer society urges lawmakers to resolve drug shortages

    With 16 ongoing oncology drug shortages disrupting patient care, a cancer society is asking lawmakers to push legislation aimed at systemic fixes to drug shortages. 
  • CVS to revamp drug pricing model 

    CVS Pharmacy is taking a cue from Mark Cuban Cost Plus Drugs and will launch a pharmacy reimbursement model built around a drug's cost, a pharmacy services fee and a set markup.
  • Why non-union pharmacists are protesting

    A tectonic shift in mindsets is inciting non-union pharmacists and other healthcare workers to protest, The New York Times reported Dec. 4. 
  • After cyberattack, patients struggle to fill scripts

    Patients of Lovelace Health System say they can't refill their prescriptions as the Albuquerque, N.M.-based system recovers from a cyberattack, Albuquerque Journal reported Dec. 1. 
  • Lawmakers probe FDA's decongestant decision

    House Republicans are investigating the FDA's regulation of a common decongestant found in over-the-counter cold medicines that the agency recently determined to be ineffective, The Hill reported Dec. 4. 
  • Eli Lilly drug gets new approval for blood cancer

    The FDA has granted approval to Eli Lilly and Company's drug Jaypirca, a therapy to treat chronic lymphocytic leukemia or small lymphocytic lymphoma.
  • ASHP: What pharmacy leaders should know heading into 2024

    More than three-fourths of hospital pharmacy leaders think health systems will cut service lines because of the rising cost and complexity of new drugs, according to a report released Dec. 4.
  • Former Allied Health pharmacy transfers to WVU Hospitals ownership

    Morgantown, W.Va.-based WVU Medicine will operate a specialty pharmacy that is currently operated by Allied Health Services, WVU Medicine's for-profit organization. 
  • AbbVie eyes commercial ovarian cancer market with ImmunoGen deal

    Pharmaceutical giant AbbVie announced plans to acquire antibody-drug conjugate maker ImmunoGen to expand its oncology portfolio and enter the commercial market for ovarian cancer. 
  • Pfizer cancels weight loss drug candidate

    Pfizer's weight loss drug candidate, danuglipron, helped patients shed between 4.8% and 13% body weight in a clinical trial involving patients with and without obesity, but the drugmaker is canceling research after more than half stopped taking the drug.
  • Walgreens launches prescription pricing tool

    Walgreens rolled out its new Rx Savings Finder on Nov. 30, a free tool offering discount cards for thousands of medications. 
  • 3 drugs nearing approval to know: Optum

    Optum Rx, a subsidiary of UnitedHealth Group, is keeping close tabs on three drug candidates that might be approved in the next few months, according to its fall 2023 report. 
  • FDA again warns drug facility where workers poured acid on quality data

    The FDA sent another warning to an Intas Pharmaceuticals plant in India, where investigators imposed import bans in late 2022 after finding shredded quality control documents doused in acid.

Featured Whitepapers

Featured Webinars